Decayed, Missing, and Filled Teeth Index and Periodontal Health in Osteoporotic Patients Affected by BRONJ: An Observational Study

Table 1

Anamnestic and clinical details of A Group—20 osteoporotic non-BRONJ patients.

Age	OS type	BP therapy	BP (years)	Associated pathology	Corticosteroid assumption	D	M	F	Periodontal probing (mm)
52	1	Ale* + Clo**	2	No	No	4	6	6	3
67	1	Clo** + Ris***	3	Diabetes mellitus II	No	6	8	5	2
59	2	Clo**	5	No	Yes	3	4	7	5
73	1	Ale*	6	No	No	3	11	2	4
77	1	Ale*	8	Rheumatoid arthritis	No	5	9	5	7
44	1	Iba****	2	No	No	2	3	4	3
61	1	Ale*	3	Rheumatoid arthritis	No	4	5	8	4
70	1	Clo** + Ris*** + Ner*****	9	Hypertension	No	4	10	6	6
49	1	Ale* + Clo**	4	No	No	3	5	3	2
55	1	Ner*****	3	No	No	4	6	8	7
78	2	Ale*	6	Rheumatoid arthritis	Yes	6	12	4	9
65	1	Ale* + Clo**	3	No	No	5	7	1	3
52	1	Ris***	2	No	No	3	4	7	6
80	1	Ale*	10	Cardiovascular diseases	No	2	18	2	9
66	2	Ale* + Clo**	4	Diabetes mellitus II	Yes	1	6	9	2
54	1	Clo** + Ris*** + Ner*****	4	No	No	3	5	8	4
47	1	Ale* + Clo**	2	No	No	0	2	6	1
71	1	Iba****	6	Diabetes mellitus II	No	2	14	3	6
59	2	Ale*	1	No	Yes	4	6	5	5
60	1	Ale* + Clo**	3	Hypertension	No	3	6	4	6

(i) Ale: alendronate: oral assumption, **Clo: clodronate: oral assumption, ***Ris: risedronate: oral assumption, ****Iba: ibandronate: oral assumption, and *****Ner: neridronate: IV assumption.
(ii) OS type: postmenopausal ostep “1”; corticosteroid related osteop “2.”